Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Change in Account Payables (2016 - 2026)

Champions Oncology has reported Change in Account Payables over the past 17 years, most recently at -$437000.0 for Q1 2026.

  • For Q1 2026, Change in Account Payables fell 132.45% year-over-year to -$437000.0; the TTM value through Jan 2026 reached $671000.0, up 829.35%, while the annual FY2025 figure was -$1.7 million, 476.13% down from the prior year.
  • Change in Account Payables for Q1 2026 was -$437000.0 at Champions Oncology, down from $1.3 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $2.1 million in Q4 2022 and troughed at -$1.2 million in Q4 2023.
  • A 5-year average of $113764.7 and a median of -$188000.0 in 2025 define the central range for Change in Account Payables.
  • On a YoY basis, Change in Account Payables climbed as much as 1443.28% in 2022 and fell as far as 635.57% in 2022.
  • Year by year, Change in Account Payables stood at $2.1 million in 2022, then crashed by 159.19% to -$1.2 million in 2023, then surged by 68.79% to -$382000.0 in 2024, then skyrocketed by 443.19% to $1.3 million in 2025, then plummeted by 133.33% to -$437000.0 in 2026.
  • Business Quant data shows Change in Account Payables for CSBR at -$437000.0 in Q1 2026, $1.3 million in Q4 2025, and $411000.0 in Q3 2025.